Header links
Intranet
Donate now
image/svg+xml Map
Contact us

Heba Gadelkareem

Heba Gadelkareem

Institutions of which they are part

Research assistant
Liver Diseases
Vall Hebron Institut de Recerca
Heba Gadelkareem

Heba Gadelkareem

Heba Gadelkareem

Institutions of which they are part

Research assistant
Liver Diseases
Vall Hebron Institut de Recerca

Related news

Grup de Malalties Hepàtiques del VHIR

A clinical trial has led to approval of the first drug for advanced fatty liver disease

Preliminary study results confirm that the drug resmetirom reduces the presence of fat, inflammation, cell damage and fibrosis in the liver.

Equip projecte ARTEMIs

We study fatty liver and cardiovascular complications with digital twins

The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.

Les Drs. María Martell i Ibane Abasolo

New treatment based on nanoparticles for chronic liver disease

The research team used nanotechnology to deliver the drug directly to liver cells, which eliminated side effects without reducing effectiveness.

See more

Related professionals

Cristina Valles Valles

Cristina Valles Valles

Childhood Cancer and Blood Disorders
Read more
Tao Gonzalez Zaragoza

Tao Gonzalez Zaragoza

Zelador/a
General Services and Infrastructure
Manager
Read more
Julia Baguña Torres

Julia Baguña Torres

Main researcher
Molecular Medical Imaging
Read more
veronica prieto aguero

veronica prieto aguero

Research technician
Clinical Research/Innovation in Pneumonia & Sepsis (CRIPS)
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.